Cara Therapeutics, a Stamford-based biopharmaceutical company, said Friday it plans to conduct a 1-for-12 reverse stock split in an effort to regain compliance with the minimum bid price requirement ...
The reverse stock split aims to help Cara Therapeutics regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Following the reverse stock split, ...
Cara Therapeutics (CARA) announced that a 1-for-12 reverse stock split of its outstanding shares of common stock and reduction in the total number of authorized shares of its common stock from 200,000 ...
STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (CARA) (the “Company”), today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results